Diagnostic Accuracy of FIB-4 Index and FIB-3 Index for Advanced Fibrosis in Chronic Liver Disease and Age-Specific

Shohei Kimura1, Nobuharu Tamaki1, Mayu Higuchi1

  • 1Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, 1-26-1 Kyonan-cho, Musashino-shi, Tokyo 180-8610, Japan.

PubMed

Insights

The FIB-3 index shows similar accuracy to the FIB-4 index for detecting liver fibrosis but performs more consistently across all age groups, making it a potentially better alternative for older adults.

Area of Science:

  • Hepatology
  • Medical Diagnostics
  • Biomarkers

Background:

  • Chronic liver diseases are prevalent, necessitating non-invasive fibrosis assessment.
  • The widely used FIB-4 index's age-dependency may limit its specificity in elderly patients.
  • The FIB-3 index, excluding age, is a proposed alternative for liver fibrosis detection.

Purpose of the Study:

  • To compare the diagnostic performance of FIB-3 and FIB-4 indices for advanced liver fibrosis.
  • To evaluate index performance across different age groups.
  • To utilize magnetic resonance elastography (MRE) as the gold standard for fibrosis assessment.

Main Methods:

  • Retrospective analysis of 3424 chronic liver disease patients (age ≥30) who underwent MRE.
  • Advanced fibrosis defined as liver stiffness ≥ 3.62 kPa.
  • Diagnostic performance and cutoff values of FIB-3 and FIB-4 evaluated in age-stratified subgroups; AUROCs compared using DeLong's test.

Main Results:

  • Both FIB-3 and FIB-4 indices showed comparable diagnostic accuracy for advanced fibrosis (AUROC 0.82).
  • FIB-4 index cutoff values increased significantly with age across quartiles.
  • FIB-3 index exhibited less variation in cutoff values across age quartiles, indicating more consistent performance.

Conclusions:

  • FIB-3 index provides diagnostic accuracy similar to FIB-4 for advanced liver fibrosis.
  • FIB-3 demonstrates more consistent performance across diverse age groups compared to FIB-4.
  • FIB-3 index is a valuable alternative, especially for older populations where FIB-4 may be less reliable due to age-related factors.